Pathware is creating hardware and software to simplify digital pathology workflows.
Pathware has raised $7.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Pathware's investors include Solas BioVentures, Keiretsu Capital, VentureWell, UnityPoint Health Ventures, TCA Venture Group.
Pathware is headquartered in Golden, United States.
Pathware is creating hardware and software to simplify digital pathology workflows.
Pathware is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pathware — Funding & Investors." VCBacked, April 19, 2022, https://www.vcbacked.co/company/pathware. Accessed August 15, 2026.
VCBacked. (2022). Pathware — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/pathware
{{cite web |title=Pathware — Funding & Investors |url=https://www.vcbacked.co/company/pathware |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated